Cargando…
P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: A meta-analysis
BACKGROUND: The 2020 European Society of Cardiology guidelines do not recommend pretreatment for nonST-segment elevation myocardial infarction (NSTEMI) patients with unclear coronary anatomy, which is inconsistent with our routine preoperative approach to loading P2Y12 receptor inhibitors (e.g., pre...
Autores principales: | Yan, Longhui, Zhou, Yan, Yu, Zhangjie, Xuan, Mengmei, Xu, Buyun, Peng, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259160/ https://www.ncbi.nlm.nih.gov/pubmed/35801776 http://dx.doi.org/10.1097/MD.0000000000029824 |
Ejemplares similares
-
Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction
por: Zheng, Zhaohai, et al.
Publicado: (2022) -
Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023) -
Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
por: Camaro, Cyril, et al.
Publicado: (2020) -
ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016) -
Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes
por: Dworeck, Christian, et al.
Publicado: (2020)